Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No compelling reason to adopt new antivirals whenever it is reasonable to wait.

Prescrire international - 1 Jan 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Enzyme Inhibitors
Share to Evidence-Based Medicine
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Sofosbuvir

Share to Uridine Monophosphate

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 25729821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No compelling reason to adopt new antivirals whenever it is reasonable to wait.PMID 25729821Read ↗

Management of direct-acting antiviral agent failuresSemantic proximity Read ↗

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read ↗

Direct-acting antivirals for acute HCV: how short can we go?Semantic proximity Read ↗

Genetic risks of antiviral nucleoside analogues – a surveySemantic proximity Read ↗

Direct-acting antivirals for paediatric HCV: we got there.Semantic proximity Read ↗

China approves first homegrown COVID antiviralSemantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

COVID drug drives viral mutations - and now some want to halt its use.Semantic proximity Read ↗

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read ↗

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.Semantic proximity Read ↗

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesSemantic proximity Read ↗

Chikungunya virus: an update on antiviral development and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.